1-9 of 9
Francisco J Márquez Malaver
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients with Lower-Risk Myelodysplastic Syndrome

Jose F. Falantes, Francisco J. Márquez-Malaver, Estrella Carrillo-Cruz, Rosario M Morales-Camacho, Concepción Prats-Martín, Teresa Caballero, Eduardo Rodriguez Arbolí, Ildefonso Espigado, Jose A. Perez-Simon
Journal: Blood
Blood (2022) 140 (Supplement 1): 6920–6922.
https://doi.org/10.1182/blood-2022-169372
Published: 2022
Journal Articles

Similar Probabilities of Failure to Reach Transplantation and Transplant Outcomes after HLA-Identical Sibling or Unrelated Donor Transplant in Patients with Acute Myeloid Leukemia: A Single Institution Evaluation of a Donor Selection Algorithm

Eduardo Rodríguez-Arbolí, MD, Francisco J. Márquez-Malaver, RN, Nancy Rodríguez-Torres, MD, Teresa Caballero-Velázquez, MD PhD, Virginia Escamilla Gomez, Cristina Calderón-Cabrera, MD, José F. Falantes, MD, Ildefonso Espigado, MD PhD, José A. Pérez-Simón
Journal: Blood
Blood (2017) 130 (Supplement 1): 5548.
https://doi.org/10.1182/blood.V130.Suppl_1.5548.5548
Published: 2017
Journal Articles

Description of Mutational Profile in Patients with Lower-Risk Myelodysplastic Syndromes at the Time of Leukemic Progression

Begoña Pedrote, Jose Francisco Falantes, Estrella Carrillo, Cristina Calderon-Cabrera, Francisco J Marquez-Malaver, Ildefonso Espigado, MD PhD, Jose A. Perez-Simon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5301.
https://doi.org/10.1182/blood.V130.Suppl_1.5301.5301
Published: 2017
Journal Articles

The Use of Busulphan As Compared to Melphalan in Combination with Fludarabine in the Reduced Intensity Conditioning Improves Overall Survival in Patients with Lymphoma

Natasha Kekre, MD FRCPC, Francisco J Marquez-Malaver, RN, Dolores Caballero, MD, Jl Piñana, MD, Albert Esquirol, MD, Robert J. Soiffer, MD, Monica Cabrero, MD, MJ Terol, Rodrigo Martino, MD PhD, Joseph H. Antin, MD, L Lopez Corral, Carlos Solano, Philippe Armand, MD PhD, Jose A. Perez-Simon, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 2007.
https://doi.org/10.1182/blood.V126.23.2007.2007
Published: 2015
Journal Articles

Results of Allogeneic Transplantation As First Line Rescue Therapy in Patients with Multiple Myeloma Relapsing to a Prior Autograft: Role of Conditioning Regimen

Jose A. Perez-Simon, MD, PhD, Francisco J Marquez-Malaver, RN, Cora Knol, Simona Iacobelli, Didier Blaise, MD PhD, Noel-Jean Milpied, MD PhD, Ellen Meijer, MDPhD, Peter Dreger, MD, Yener Koc, MD, Eefke Petersen, MD PhD, Mauricette Michallet, MD PhD, Laurent Garderet, Nicolaus Kroeger, MD
Journal: Blood
Blood (2015) 126 (23): 4373.
https://doi.org/10.1182/blood.V126.23.4373.4373
Published: 2015
Journal Articles

Strategies for Graft Versus Host Disease Prophylaxis after Reduced-Intensity Conditioning Transplantation: Combination of Sirolimus Plus Tacrolimus Allows to Obtain the Best Outcome

Rocío Parody, MDPhD, Dolores Caballero, Martinez Carmen, MD PhD, Rodrigo Martino, MD PhD, Carlos Solano, Pere Barba, MD, Lucía López-Corral, MD PhD, Oriana Lopez Godino, MD, Lourdes Vazquez, MD, Montserrat Rovira, MD PhD, Francesc Fernandez-Avilés, Albert Esquirol, MD, Irene García Cadenas, José Luís Piñana, David Valcarcel, MD PhD, Francisco J. Marquez-Malaver, Jose Antonio Perez-Simón, MDPhD
Journal: Blood
Blood (2014) 124 (21): 1165.
https://doi.org/10.1182/blood.V124.21.1165.1165
Published: 2014
Journal Articles

The Presence Of 1 / 8 HLA Mismatch Do Not Hamper Survival After Allogeneic Stem Cell Transplantation Using Immunoprophylaxis With Sirolimus-Tacrolimus

Rocío Parody, MD, PhD, Lucía López-Corral, MD, PhD, Oriana Lopez Godino, MD, Irene García Cadenas, Vazquez Lourdes, MD, Rodrigo Martino, MD, PhD, Carmen Martinez, Carlos Solano, Ariadna Perez Martinez, Pere Barba, MD, David Valcarcel, MD, Jose F. Falantes, MD, Francisco J Márquez-Malaver, Dolores Caballero, MD, PhD, Jose Antonio Perez-Simón, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4529.
https://doi.org/10.1182/blood.V122.21.4529.4529
Published: 2013
Journal Articles

Azacitidine Alone Or The Combination With Valproic Acid As a Bridge Therapy For Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes Before Transplantation

Cristina Calderón Cabrera, Jose F Falantes, MD, Marina Gómez, Rocío Parody, MD, PhD, Francisco J Márquez Malaver, María L Martino, José González, Isabel Montero, Ildefonso Espigado, Jose Antonio Pérez-Simón
Journal: Blood
Blood (2013) 122 (21): 2812.
https://doi.org/10.1182/blood.V122.21.2812.2812
Published: 2013
Journal Articles

Multivariable Time-Dependent Analysis Of The Impact Of 5 Azacitidine In Patients With Lower-Risk Myelodysplastic Syndrome and Unfavorable Specific Lower-Risk Score

Jose F Falantes, MD, Regina García Delgado, Cristina Calderón, MD, David Valcarcel, MD, Julia Montoro, MD, Dunia De Miguel, Francisco J Márquez-Malaver, Alicia Bailen, MD, Joan Bargay, MD, Teresa Bernal, MD, Jose R Gonzalez-Porras, MD, Mar Tormo, MD, Fernando Ramos, Rafael Andreu, Blanca Xicoy, MD, PhD, Benet Nomdedeu, MD, PhD, Salut Brunet, Joaquin Sanchez, MD, Antonio Fernández Jurado, Santiago Bonanad, MD, Ildefonso Espigado, MD, PhD, Jose Antonio Pérez-Simón, MD, PhD, Guillermo Sanz, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2754.
https://doi.org/10.1182/blood.V122.21.2754.2754
Published: 2013